Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 1Phase 4 1Phase 2/3 1

Status

Completed 4Terminated 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4Other 1

Conditions

Prostatic Neoplasms 4Sexual Dysfunction, Physiological 1Infertility 1

Interventions

Cyclophosphamide 741Cisplatin 688Gemcitabine 641Bevacizumab 616Carboplatin 605Paclitaxel 601Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 361Capecitabine 342Filgrastim 333Etoposide 330Dexamethasone 312Irinotecan 309pembrolizumab 282Leucovorin 274Cetuximab 268Cytarabine 242Erlotinib Hydrochloride 231Nivolumab 228Prednisone 227Trastuzumab 225Vincristine 221Bortezomib 221Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Completed × Finasteride × Clear all
NCT02213107 2024-11-13

Enzalutamide & Dutasteride/Finasteride as 1st Line Treatment for Patients =/> 65 Years Old With Prostate Cancer.

University of Rochester

Phase 2 Completed
43 enrolled 10 charts
Genitourinary

Prostatic Neoplasms

NCT00736645 2023-10-02

Selenomethionine and Finasteride Before Surgery or Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer

Roswell Park Cancer Institute

Phase 2 Completed
55 enrolled 11 charts
Genitourinary

Prostatic Neoplasms

NCT00003323 2016-07-04

Hormone Therapy in Treating Patients With Prostate Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Completed
101 enrolled
GenitourinaryOther

Infertility, Prostatic Neoplasms, Sexual Dysfunction, Physiological

NCT00438464 2016-03-09

Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery

National Cancer Institute (NCI)

Phase 2 Completed
204 enrolled 28 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡